Industry Experts

Neal Van Hoeven is the vice president of preclinical research at Cabaletta Bio in Philadelphia. He has over 20 years of experience designing and testing novel gene and cell therapies. Following initial training in the laboratory of Dr. Dusty Miller at the Fred Hutchinson cancer research center in Seattle and a postdoctoral fellowship at the Centers for Disease Control and Prevention in Atlanta, GA, he has held research and leadership positions in a number of gene and cell therapy companies including Immune Design Corp., The Infectious Disease Research Institute, and Sana Biotechnology.